The Case | Severe hypertension and hyperkalemia in a kidney transplant recipient
A 55-year-old man with a history of end-stage renal disease due to autosomal dominant polycystic kidney disease and bilateral nephrectomy without adrenalectomy underwent his first kidney transplantation after 6 years of hemodialysis. The patient had no history of donor-specific antibodies. The donor was described as a 69-year-old man with a history of active smoking and aortic valvulopathy who died of a stroke without cardiac arrest or collapse. Maintenance immunosuppressive therapy consisted of low-dose tacrolimus and everolimus.
Source: Kidney International - Category: Urology & Nephrology Authors: Vincent Dupont, Charlotte Colosio, Marguerite Hureaux, Laetitia Mokri, Betoul Schvartz, Vincent Vuiblet, Antoine Braconnier, Rosa Vargas-Poussou, Philippe Rieu Tags: Make Your Diagnosis Source Type: research
More News: Dialysis | Hemodialysis | Hypertension | Kidney Transplant | Kidney Transplantation | Nephrectomy | Polycystic Kidney Disease | Prograf | Smokers | Stroke | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology